XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.13

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7686)	11/8/1998 1:42:00 AM
From: aknahow	Read Replies (1) of 17367

Too many big words and the phrase, "may be useful" is not quite the same as "may cure cancer." If BPI works I think there will be real stories. Tashika is a real person and her survival was and is a real story. The only problem is there was no statistical proof that Neuprex caused her recovery. Once cause and effect can be shown there will be stories. But first we have to get there. There will be stories before approval or non approval but IMO they just won't or can't or should not be expected to be ENMD impact articles. If you disagree write a post of the story you think will hit the times, CNBC and be understood in no more than five words by the general public. You know like, "longivity", or "cures cancer" or "kills flesh eating bacteria". Can't be done, but take a stab at it!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next